Reaction Details |
| Report a problem with these data |
Target | Bombesin receptor subtype-3 |
---|
Ligand | BDBM50314979 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_627760 (CHEMBL1116182) |
---|
IC50 | 10±n/a nM |
---|
Citation | Liu, J; He, S; Jian, T; Dobbelaar, PH; Sebhat, IK; Lin, LS; Goodman, A; Guo, C; Guzzo, PR; Hadden, M; Henderson, AJ; Pattamana, K; Ruenz, M; Sargent, BJ; Swenson, B; Yet, L; Tamvakopoulos, C; Peng, Q; Pan, J; Kan, Y; Palyha, O; Kelly, TM; Guan, XM; Howard, AD; Marsh, DJ; Metzger, JM; Reitman, ML; Wyvratt, MJ; Nargund, RP Synthesis and SAR of derivatives based on 2-biarylethylimidazole as bombesin receptor subtype-3 (BRS-3) agonists for the treatment of obesity. Bioorg Med Chem Lett20:2074-7 (2010) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Bombesin receptor subtype-3 |
---|
Name: | Bombesin receptor subtype-3 |
Synonyms: | BRS-3 | BRS3 | BRS3_HUMAN | Bombesin 3 | Bombesin like receptor 3 |
Type: | Enzyme Catalytic Domain |
Mol. Mass.: | 44424.45 |
Organism: | Homo sapiens (Human) |
Description: | Bombesin 3 BRS3 HUMAN::P32247 |
Residue: | 399 |
Sequence: | MAQRQPHSPNQTLISITNDTESSSSVVSNDNTNKGWSGDNSPGIEALCAIYITYAVIISV
GILGNAILIKVFFKTKSMQTVPNIFITSLAFGDLLLLLTCVPVDATHYLAEGWLFGRIGC
KVLSFIRLTSVGVSVFTLTILSADRYKAVVKPLERQPSNAILKTCVKAGCVWIVSMIFAL
PEAIFSNVYTFRDPNKNMTFESCTSYPVSKKLLQEIHSLLCFLVFYIIPLSIISVYYSLI
ARTLYKSTLNIPTEEQSHARKQIESRKRIARTVLVLVALFALCWLPNHLLYLYHSFTSQT
YVDPSAMHFIFTIFSRVLAFSNSCVNPFALYWLSKSFQKHFKAQLFCCKAERPEPPVADT
SLTTLAVMGTVPGTGSIQMSEISVTSFTGCSVKQAEDRF
|
|
|
BDBM50314979 |
---|
n/a |
---|
Name | BDBM50314979 |
Synonyms: | 4-(4-(2-(4-(2,2-dimethylbutyl)-1H-imidazol-2-yl)ethyl)phenyl)isothiazole | CHEMBL1082471 |
Type | Small organic molecule |
Emp. Form. | C20H25N3S |
Mol. Mass. | 339.498 |
SMILES | CCC(C)(C)Cc1cnc(CCc2ccc(cc2)-c2cnsc2)[nH]1 |
Structure |
|